Purchases and Sales Made in Q2 2023 in Virax Biolabs Group LTD (VRAX)
This table provides information about the institutional ownership of Virax Biolabs Group LTD (VRAX) during Q2 2023. The information is specifically focused on institutions that hold shares of Virax Biolabs Group Ltd.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
24.6KNew |
$8.36K - $16.7K
|
24.6K
$48.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
12.6KNew |
$4.28K - $8.55K
|
12.6K
$24.8K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2KNew |
$680 - $1.36K
|
2K
$3.94K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-6.62K- 26.72% |
$2.25K - $4.5K
|
18.2K
$35.8K
|